ghmpns | 20759
MPN sequential testing
Keywords:
CALR Exon 9 Mutation
JAK2 Mutation Exon 12
JAK2 Mutation p.V617F
MPL p.W515 Mutation
Myeloproliferation
Myleoproliferative Neoplasm
Status
Material |
|
||
---|---|---|---|
Hint |
JAK2 p.V617F Mutation > JAK2 Mutation Exon 12 > CALR Exon 9 Mutation > MPL p.W515 Mutation | To be determined within 24h from sampling. | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).
|
||
Min. volume | 4 mL | ||
Stability |
Stability
1 day / 18-25°C; 1 day / 2-8°C
|
||
Duration | 5 days | ||
Frequency | 2 x per week | ||
Method | Next Generation Sequencing |
Price/Rate
Price |
Price
CHF 1’882.40
|
---|---|
Rate |
Rate
1'882.40 TP
|
Single Analysis
MPL p.W155 Mutation | ghmpl | Blood EDTA |
---|---|---|
Calreticulin | ghcal | Blood EDTA |
JAK2 Mutation Exon 12 | jak2e | Blood EDTA |
JAK2 mutation p.V617F | jak2 | Blood EDTA |